Mounjaro is the brand name for tirzepatide, a prescription medicine given as an injection once a week. In Australia, it's approved for adults with type 2 diabetes, and for weight management in eligible adults alongside a reduced-calorie diet and more physical activity.
Tirzepatide works on two hormone systems in the body, known as GIP and GLP-1, which are involved in regulating blood sugar, appetite, and feelings of fullness. Doctors typically start patients on a low dose and increase it gradually, depending on how they respond and any side effects.
Common side effects include nausea, diarrhoea, vomiting, constipation, and stomach discomfort. Mounjaro isn't suitable for everyone, and people taking the oral contraceptive pill, planning a pregnancy, or preparing for surgery should tell their doctor. As with any prescription medicine, dose changes need medical supervision, and weight loss results vary from person to person.
Book a telehealth consultation with an AHPRA-registered GP for assessment, prescriptions, referrals or advice.
Book ConsultationMounjaro is the brand name for tirzepatide, a weekly injection approved in Australia for type 2 diabetes and weight management.
No. This glossary explains general health terminology, not your individual symptoms or test results. Speak with a qualified health professional for advice about your circumstances. For a medical emergency, call 000.
Proudly Australian-owned and operated